908 Devices MASS
NASDAQ MASS
$10.35 +0.11 (+1.07%)
At close: Aug 20, 2026 · 4:00 PM EDT

908 Devices (MASS) Total Non-Current Liabilities (2020 - 2026)

908 Devices (MASS) posted quarterly Total Non-Current Liabilities of $52.5 million for Q1 2026, up 64.97% year-over-year from $31.8 million in Q1 2025, and up 13.28% quarter-over-quarter from $46.3 million in Q4 2025.

908 Devices (MASS) Total Non-Current Liabilities (2020 - 2026) Analysis & Trends

908 Devices (MASS) has reported Total Non-Current Liabilities for 7 consecutive years, with $52.5 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Total Non-Current Liabilities rose 64.97% year-over-year to $52.5 million; the TTM figure through Mar 2026 stood at $52.5 million (up 64.97% YoY), while the FY2025 annual figure was $46.3 million, up 8.78% from the prior year.
  • Total Non-Current Liabilities improved to $52.5 million in Q1 2026 per MASS's latest filing, from $46.3 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $54.5 million in Q3 2025 and bottomed at $31.8 million in Q1 2025.
  • Historically, Total Non-Current Liabilities has averaged $44.2 million across 5 years, with a median of $43.9 million in 2024.
  • Annual changes were most pronounced in 2024 — Total Non-Current Liabilities climbed 1.93% — and 2026, when it surged 64.97%.
  • 908 Devices' Total Non-Current Liabilities stood at $51.4 million in 2022, then decreased by 29.59% to $36.2 million in 2023, then grew by 17.63% to $42.6 million in 2024, then rose by 8.78% to $46.3 million in 2025, then grew by 13.28% to $52.5 million in 2026.
  • Business Quant data shows MASS's Total Non-Current Liabilities at $52.5 million in Q1 2026, $46.3 million in Q4 2025, and $54.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn -
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 21.28 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 40.90 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 42.74 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 2.57 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn 3.68 Bn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 23.89 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 9.07 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 3.44 Bn
10 908 Devices 387.65 Mn 286.12 Mn 8.34 Mn 64.91 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 64.91 Mn
Mar 31, 2026 52.49 Mn
Dec 31, 2025 46.34 Mn
Sep 30, 2025 54.54 Mn
Mar 31, 2025 31.82 Mn
Dec 31, 2024 42.60 Mn
Sep 30, 2024 43.89 Mn
Jun 30, 2024 36.92 Mn
Jun 30, 2023 36.22 Mn
Mar 31, 2023 37.67 Mn
Dec 31, 2022 51.43 Mn
Sep 30, 2022 52.24 Mn
Sep 30, 2021 43.33 Mn
Jun 30, 2021 39.62 Mn
Mar 31, 2021 38.24 Mn
Dec 31, 2020 39.59 Mn